80 related articles for article (PubMed ID: 26117918)
1. [BIOMARKER CONTENT AND ROLE IN HOSPITAL PERIOD OF ACUTE CORONARY SYNDROME].
Mikhaĭlova ZD; Shalenkova MA; Maniukova ET
Klin Med (Mosk); 2015; 93(2):47-52. PubMed ID: 26117918
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.
Ranjith N; Pegoraro RJ; Naidoo DP; Esterhuizen TM
Cardiovasc J S Afr; 2006; 17(2):60-6. PubMed ID: 16733598
[TBL] [Abstract][Full Text] [Related]
3. [ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: POSSIBILITIES FOR PREDICTING THE CLINICAL COURSE AT THE POST-HOSPITAL (6 AND 12 MONTHS) STAGE].
Klin Med (Mosk); 2016; 94(3):205-10. PubMed ID: 27522726
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
Liu WX; Zhao H
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
[TBL] [Abstract][Full Text] [Related]
5. NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes.
Zdravkovic V; Mladenovic V; Colic M; Bankovic D; Lazic Z; Petrovic M; Simic I; Knezevic S; Pantovic S; Djukic A; Zdravkovic N
Kardiol Pol; 2013; 71(5):472-9. PubMed ID: 23788087
[TBL] [Abstract][Full Text] [Related]
6. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
[TBL] [Abstract][Full Text] [Related]
7. Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes.
De Servi S; Mariani G; Piatti L; Leoncini M; Rubartelli P; Pitì A; Curello S; Galdangelo F; Vandoni P; Rossetti E; Mariani M; Boschetti E; Re G; Loznicker M
J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):42-7. PubMed ID: 24492354
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
[TBL] [Abstract][Full Text] [Related]
10. Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA.
Tillmanns J; Widera C; Habbaba Y; Galuppo P; Kempf T; Wollert KC; Bauersachs J
Int J Cardiol; 2013 Oct; 168(4):3926-31. PubMed ID: 23932048
[TBL] [Abstract][Full Text] [Related]
11. Association study of plasma NT-proBNP levels and severity of acute coronary syndrome.
Tuxunguli T; Aierken A; Xie X; Dai CF; Yang YN; Li XM; Ma YT
Genet Mol Res; 2014 Jul; 13(3):5754-7. PubMed ID: 25117333
[TBL] [Abstract][Full Text] [Related]
12. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy.
Fröhlich GM; Schoch B; Schmid F; Keller P; Sudano I; Lüscher TF; Noll G; Ruschitzka F; Enseleit F
Int J Cardiol; 2012 Feb; 154(3):328-32. PubMed ID: 22044675
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of biomarkers for risk prediction in acute coronary syndrome-Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study.
Kaski JC; Fernández-Bergés DJ; Consuegra-Sánchez L; Fernández JM; García-Moll X; Mostaza JM; Cebada RT; Juanatey JR; Martínez GG; Marrugat J
Atherosclerosis; 2010 Oct; 212(2):636-43. PubMed ID: 20619836
[TBL] [Abstract][Full Text] [Related]
14. [Peculiarities of dynamics and prognostic value of NT-proBNP level in different variants of treatment of patients with acute coronary syndrome].
Shreĭder EV; Shakhnovich RM; Bosykh EG; Ruda MIa
Kardiologiia; 2010; 50(2):15-20. PubMed ID: 20146673
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction.
Drewniak W; Snopek G; Zarukiewicz M; Borys M; Dabrowski M
Kardiol Pol; 2008 Jul; 66(7):750-5; discussion 756-7. PubMed ID: 18690566
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
[TBL] [Abstract][Full Text] [Related]
17. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
[TBL] [Abstract][Full Text] [Related]
18. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris.
Wudkowska A; Goch J; Goch A
Kardiol Pol; 2010 Apr; 68(4):431-7. PubMed ID: 20425705
[TBL] [Abstract][Full Text] [Related]
19. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP.
Squire I; Quinn P; Narayan H; Khan S; Dhillon O; Ng K; Kelly D; Davies J; Ng L
Heart; 2010 Jun; 96(11):831-7. PubMed ID: 20478862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
